These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. Uthaipibull C; Aufiero B; Syed SE; Hansen B; Guevara Patiño JA; Angov E; Ling IT; Fegeding K; Morgan WD; Ockenhouse C; Birdsall B; Feeney J; Lyon JA; Holder AA J Mol Biol; 2001 Apr; 307(5):1381-94. PubMed ID: 11292349 [TBL] [Abstract][Full Text] [Related]
44. Reduction of disulfide bonds in Plasmodium falciparum gp195 abolishes the production of growth-inhibitory antibodies. Locher CP; Tam LQ Vaccine; 1993; 11(11):1119-23. PubMed ID: 8249430 [TBL] [Abstract][Full Text] [Related]
45. Characterisation of an inhibitory monoclonal antibody-defined epitope on a malaria vaccine candidate antigen. Ramasamy R; Jones G; Lord R Immunol Lett; 1990 Feb; 23(4):305-9. PubMed ID: 1693361 [TBL] [Abstract][Full Text] [Related]
46. Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum. Chang SP; Hui GS; Kato A; Siddiqui WA Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6343-7. PubMed ID: 2668963 [TBL] [Abstract][Full Text] [Related]
47. Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro. Moreno R; Pöltl-Frank F; Stüber D; Matile H; Mutz M; Weiss NA; Pluschke G Infect Immun; 2001 Apr; 69(4):2558-68. PubMed ID: 11254620 [TBL] [Abstract][Full Text] [Related]
48. Peptides reactive with a transmission-blocking monoclonal antibody against Plasmodium falciparum Pfs25: 2000-fold affinity increase by PEPSCAN-based amino acid substitutions. van Amerongen A; Beckers PJ; Plasman HH; Schaaper WM; Sauerwein RW; Meuwissen JH; Meloen RH Pept Res; 1992; 5(5):269-74. PubMed ID: 1280492 [TBL] [Abstract][Full Text] [Related]
50. Two immunogenic peptide conjugates derived from P. falciparum MSA2 give rise to antibodies that crossreact with a nonhomologous 195-kDa malarial protein. Lord R; Jones G; Saul A Pept Res; 1993; 6(4):191-4. PubMed ID: 8400614 [TBL] [Abstract][Full Text] [Related]
51. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195. Hui GS; Tam LQ; Chang SP; Case SE; Hashiro C; Siddiqui WA; Shiba T; Kusumoto S; Kotani S Infect Immun; 1991 May; 59(5):1585-91. PubMed ID: 2019429 [TBL] [Abstract][Full Text] [Related]
52. Analysis of the high molecular weight rhoptry complex of Plasmodium falciparum using monoclonal antibodies. Doury JC; Bonnefoy S; Roger N; Dubremetz JF; Mercereau-Puijalon O Parasitology; 1994 Apr; 108 ( Pt 3)():269-80. PubMed ID: 7517517 [TBL] [Abstract][Full Text] [Related]
53. Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate. Chang SP; Kramer KJ; Yamaga KM; Kato A; Case SE; Siddiqui WA Exp Parasitol; 1988 Oct; 67(1):1-11. PubMed ID: 3049134 [TBL] [Abstract][Full Text] [Related]
54. Production and preliminary characterization of murine monoclonal antibodies to Ichthyophthirius multifiliis, a protozoan parasite of fish. Dickerson HW; Evans DL; Gratzek JB Am J Vet Res; 1986 Nov; 47(11):2400-4. PubMed ID: 2431637 [TBL] [Abstract][Full Text] [Related]
55. Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes. Lyon JA; Thomas AW; Hall T; Chulay JD Mol Biochem Parasitol; 1989 Aug; 36(1):77-85. PubMed ID: 2509909 [TBL] [Abstract][Full Text] [Related]
56. Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene. Lyon JA; Geller RH; Haynes JD; Chulay JD; Weber JL Proc Natl Acad Sci U S A; 1986 May; 83(9):2989-93. PubMed ID: 2422662 [TBL] [Abstract][Full Text] [Related]
57. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. Lee N; Baker J; Andrews KT; Gatton ML; Bell D; Cheng Q; McCarthy J J Clin Microbiol; 2006 Aug; 44(8):2773-8. PubMed ID: 16891491 [TBL] [Abstract][Full Text] [Related]
58. High titer response against a malarial antigen depends on the flanking sequence of the immunizing peptide conjugate. Jones GL; Gale J; Lord R; Edmundson HM; Saul A; Pye D Pept Res; 1989; 2(4):282-5. PubMed ID: 2520766 [TBL] [Abstract][Full Text] [Related]
59. Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum. Alifrangis M; Christensen IT; Jørgensen FS; Rønn AM; Weng JE; Chen M; Bygbjerg IC; Sirawaraporn W; Palarasah Y; Koch C Malar J; 2004 Jun; 3():16. PubMed ID: 15193156 [TBL] [Abstract][Full Text] [Related]
60. Cross-reactivity of antibody against an epitope of the Plasmodium falciparum second merozoite surface antigen. Saul A; Lord R; Jones G; Geysen HM; Gale J; Mollard R Parasite Immunol; 1989 Nov; 11(6):593-601. PubMed ID: 2482473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]